Skip to content

Attila Kovács

6 papers in the library · 223 citations · publishing 2014-2026

Papers

Sort Most recent Most cited

Reflective Control in Gaming Addiction: A Paradox?

Human Arenas July 10, 2026 Attila Kovács

Abstract Gaming addiction is a complex phenomenon that extends beyond behavioral reinforcement and neurochemical dysregulation. This study adopts a phenomenological approach, integrating Husserl’s active and passive synthesis with Heidegger’s existential structures and Arvidson’s conceptualization of attention, to explore how gaming addiction reshapes reflective awareness, attentional control...

The protective effect of DMT against neurodegeneration.

International review of neurobiology 2025 Ede Frecska, Attila Kovács, Attila Szabo 2 citations

This paper explores the therapeutic potential of DMT in neuroprotective strategies, particularly concerning ischemia-reperfusion injury (IRI) and neurodegenerative disorders. Besides its potent serotonin receptor actions, DMT is also an endogenous agonist of the sigma-1 receptor (Sig-1R). Sigma receptors are a unique family of proteins with high expression in the brain and spinal cord and have...

The Potential Use of Dimethyltryptamine against Ischemia-reperfusion Injury of the Brain

Journal of Neuroscience and Neurological Disorders April 19, 2024 Attila Kovács, Anna Mathe, Ede Frecska 2 citations

Ischemia-Reperfusion Injury (IRI) is the outcome of two intertwined pathological processes resulting from the shortage of blood flow to tissues and the subsequent restoration of circulation to a previously ischemic area. IRI (sometimes just one side of the dyad) remains one of the most challenging problems in several branches of emergency medicine. Mitochondrial and endoplasmic reticulum...

Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye

Biomedicines April 26, 2022 Anna Szilágyi, Barbara Takács, Réka Szekeres et al. 10 citations

Ischemic eye diseases are major causes of vision impairment. Thus, potential retinoprotective effects of N’N-dimethyltryptamine (DMT) were investigated. To inhibit its rapid breakdown by monoamine-oxidase A (MAO-A) enzyme, DMT was co-administered with harmaline, a β-carboline in the Amazonian Ayahuasca brew. Using ligation, 60 min of ischemia was provoked in eyes of rats, followed by 7 days of...

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

Frontiers in Neuroscience September 14, 2016 Attila Szabo, Attila Kovács, Jordi Riba et al. 18 citations

N,N-dimethyltryptamine (DMT) is a potent endogenous hallucinogen present in the brain of humans and other mammals. Despite extensive research, its physiological role remains largely unknown. Recently, DMT has been found to activate the sigma-1 receptor (Sig-1R), an intracellular chaperone fulfilling an interface role between the endoplasmic reticulum (ER) and mitochondria. It ensures the...

Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.

PLoS One 2014 Attila Szabo, Attila Kovács, Ede Frecska et al. 191 citations

The orphan receptor sigma-1 (sigmar-1) is a transmembrane chaperone protein expressed in both the central nervous system and in immune cells. It has been shown to regulate neuronal differentiation and cell survival, and mediates anti-inflammatory responses and immunosuppression in murine in vivo models. Since the details of these findings have not been elucidated so far, we studied the effects...